Issue No. 6 · Week of September 21, 2026
The biggest signal for foreign manufacturers this week is on the federal side: Senzime’s exclusive five year VA contract shows how to reach more than 170 VA hospitals without a single facility by facility bid, and CBP’s new supply chain disclosure rulemaking is an early warning that import paperwork is about to get more demanding. FDA also keeps quietly turning De Novo approvals into Class II predicates, making the 510(k) pathway the default route for surgical robotics and AI enabled software. North of the border, Ontario’s funding cuts are tightening hospital budgets even as Winnipeg breaks ground on a $300 million capital project, a split worth watching if you sell into both markets.
Hospitals and Health Systems
Atrium Health breaks ground on $116 million patient tower in fast-growing Charlotte suburb
Atrium Health Union West in Stallings, North Carolina broke ground on a $116 million, 67,000 square foot tower adding 88 patient rooms, 11 emergency department bays, a procedure room and an endoscopy room, targeted to open in fall 2028, after patient visits at the four year old hospital rose 127 percent. Even a recently built community hospital can outgrow its capacity fast, and projects like this open a multi year window to get imaging, monitoring and procedural equipment on the list before opening day.
Source: Hoodline
Winnipeg breaks ground on $300 million Healthcare Centre of Excellence inside a redeveloped mall
Manitoba is building a $300 million, 300,000 square foot, 12 story Healthcare Centre of Excellence inside the redeveloped Portage Place mall in downtown Winnipeg, part of a larger $650 million project combining primary care, diagnostic imaging, surgical suites and dialysis under one roof by late 2028. It is a large, funded, multi year Canadian capital project worth tracking early for imaging, surgical and dialysis equipment tenders.
Source: Canadian Healthcare Technology
Jackson Hospital in Montgomery, Alabama emerges from Chapter 11 bankruptcy
Jackson Hospital formally emerged from Chapter 11 protection after years of financial strain, and CEO John Quinlivan said the hospital can now access $40 million in pledged state funding to pursue physician recruitment, specialty expansion and capacity growth that were on hold during reorganization. For vendors, a hospital emerging from bankruptcy with fresh state backing signals renewed purchasing capacity and credit standing after a period when new contracts and capital spending were likely frozen.
Source: WSFA 12 News
Unsterile surgical instruments disrupt operations at hospitals in the US and Canada
A roundup of sterile processing failures this year found contaminated or unsterile instruments reaching operating rooms at hospitals in California and Pennsylvania, and at Grande Prairie Regional Hospital in Alberta, where instruments were twice found still carrying visible tissue from a prior use, forcing canceled or delayed surgeries on both sides of the border. It is a reminder that clear, testable reprocessing instructions and hospital facing validation matter for any manufacturer of reusable surgical instruments.
Source: Healthcare Purchasing News
Federal Health Systems: VA and DoD
Swedish device maker Senzime wins exclusive five year VA national supply contract
Swedish manufacturer Senzime, working through federal distributor TrillaMed, a service disabled veteran owned small business, secured an exclusive five year national contract making its TetraGraph neuromuscular monitoring system the only option of its kind available through the VA’s Strategic Acquisition Center, opening a path into more than 170 VA hospitals without separate local bids. It is a concrete example of how a foreign manufacturer can reach the VA market at national scale by partnering with a veteran owned federal distributor rather than pursuing facility by facility sales.
Source: Senzime AB via Yahoo Finance
Regulatory: FDA and Health Canada
FDA finalizes classification of ENT surgical robot as a Class II device
FDA published a final rule classifying the cooperative powered surgical assist device for ENT surgery, a robotic platform that assists a surgeon’s hand movements during ear, nose and throat procedures, into Class II with special controls covering software validation, electrical and thermal safety, biocompatibility, sterility and labeling. Formal codification lets later entrants use the faster 510(k) pathway instead of filing their own De Novo request, a pattern worth tracking for any manufacturer developing surgical robotics in this specialty.
Source: Federal Register, FDA
FDA files proposed exemption from premarket notification for AI radiology triage and detection devices
FDA filed a proposed rule that would exempt certain radiology computer aided detection and diagnosis devices and computer aided triage and notification devices, a category of AI driven imaging software, from the standard 510(k) premarket notification requirement before qualifying products can be marketed. For a foreign manufacturer developing radiology AI or imaging triage software, this points toward a faster and cheaper path to the US market once finalized, though the exact device criteria will need to be checked closely against any specific product.
Source: Federal Register, FDA
CMS expands ACCESS digital health payment pilot to heart failure, COPD and three other chronic conditions
CMS is expanding its ACCESS model, which pays participating health organizations for using digital technologies to manage chronic disease based on outcomes, to cover heart failure, COPD, substance use disorders, tobacco cessation and musculoskeletal support starting spring 2027, with more than 160 companies already enrolled. Paired with FDA’s companion TEMPO pilot for real world evidence, this widens the reimbursement and market entry runway for any manufacturer with a connected or software driven device.
Source: MedTech Dive
Import, Customs and Trade
CBP opens advance rulemaking on heightened import disclosures for supply chain visibility
CBP published an advance notice of proposed rulemaking, comments due December 1, that would require importers to submit foreign export documentation and enhanced manufacturer and supplier identifiers, and to use supply chain tracing technology showing CBP where imported goods and their inputs actually come from. The notice asks for comment on special treatment for critical medical products but proposes no exemption yet, an early but important one to watch for any foreign manufacturer or importer of record relying on a broker or distributor to bring devices into the United States.
Source: Federal Register, U.S. Customs and Border Protection
Also Noted
McKesson discloses cyberattack exposing 284 million customer records
McKesson disclosed a cyberattack exposing 284 million customer records, and the ShinyHunters group is demanding a $55 million ransom.
Source: Inc. / SEC filing
Ontario hospital deficits grow as provincial funding shifts
Ontario Health Coalition report ties provincial funding cuts to public hospital deficits as private clinic funding grows.
Source: Ontario Health Coalition
Key Takeaways for Medical Device Manufacturers
This week’s developments highlight several routes into the North American market beyond traditional facility by facility sales. Senzime’s VA contract demonstrates how a foreign manufacturer can reach the federal healthcare system nationally through an experienced veteran owned distributor, while new FDA classifications and proposed exemptions could create more streamlined regulatory pathways for certain surgical robotics and AI enabled imaging products.
At the same time, CBP’s proposed supply chain disclosure requirements reinforce the importance of maintaining detailed manufacturer, supplier and origin information. Manufacturers selling into Canada should also continue watching the contrast between major new capital projects and tightening provincial hospital budgets.
Questions About U.S. or Canadian Market Access?
Dawa Medical supports foreign medical device manufacturers entering the U.S. market as U.S. Agent, FDA Initial Importer and Importer of Record, with 3PL warehousing and regulatory compliance support. Through TB Medical Inc., manufacturers can also access Canadian importation and distribution support.
About The Access Brief: The Access Brief summarizes publicly reported news affecting medical device manufacturers selling into the United States and Canada and reflects Dawa Medical’s own understanding. It is not legal, regulatory or binding advice, and formal advice should come from qualified counsel or a specialist consultant.
